机构:[1]College of Life Science, Sichuan Normal University, Chengdu, Sichuan 610101, China; Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.[2]Zhuji People's Hospital Affiliated to Wenzhou Medical University, Zhuji, Zhejiang 311899, China.[3]Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.[4]Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China; Hangzhou Medical College, Hangzhou, Zhejiang 310059, China.[5]College of Life Science, Sichuan Normal University, Chengdu, Sichuan 610101, China. Electronic address: liqun01234@163.com.[6]Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China; Hangzhou Medical College, Hangzhou, Zhejiang 310059, China. Electronic address: limingqian613@163.com.
第一作者机构:[1]College of Life Science, Sichuan Normal University, Chengdu, Sichuan 610101, China; Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
推荐引用方式(GB/T 7714):
Zou Hongling,Chen Yan,Zhu Xinping,et al.Corrigendum to ''Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation'' [Biomed. Pharma. 177 (2024) 117105[J].BIOMEDICINE & PHARMACOTHERAPY.2024,117213.doi:10.1016/j.biopha.2024.117213.
APA:
Zou Hongling,Chen Yan,Zhu Xinping,Zhao Xinyun,Cao Jili...&Li Mingqian.(2024).Corrigendum to ''Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation'' [Biomed. Pharma. 177 (2024) 117105.BIOMEDICINE & PHARMACOTHERAPY,,
MLA:
Zou Hongling,et al."Corrigendum to ''Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation'' [Biomed. Pharma. 177 (2024) 117105".BIOMEDICINE & PHARMACOTHERAPY .(2024):117213